Clinical Trial vs Standard of Care: What Joining a Parkinson's Trial Actually Changes
One of the most common worries families share before considering a Parkinson's trial is also one of the simplest. If we join a trial, do we have to give up our regular care? The short answer is almost always no. Standard of care continues. The trial gets layered on top of it.
What Standard of Care Means
Standard of care is the medical care a person already gets for their Parkinson's disease. Appointments with a neurologist, a treatment plan often built around levodopa or related medications, sometimes physical therapy or speech therapy, and other support depending on symptoms. None of that has to change to join a trial.
What Joining a Trial Adds
- A screening visit to confirm eligibility.
- Regular study visits at a research site, in addition to regular neurology appointments.
- An experimental treatment, an active comparator, or in some trials a placebo.
- Detailed measurements like UPDRS scoring, sleep tracking, cognitive testing, blood work, and sometimes imaging.
- At home tasks like questionnaires or wearing a monitoring device.
What Stays the Same
- Existing medications, often levodopa, continue throughout the study unless the trial is specifically testing a change.
- Your regular neurologist keeps managing your family member's care. The study team coordinates with them.
- Insurance and primary care continue as before. Study related care is paid for by the trial.
- Participation is voluntary. Your family member can leave at any time, for any reason, without affecting their regular care.
What Is Different
- More appointments, layered on top of regular care.
- More detailed measurement of symptoms and quality of life.
- The possibility of receiving an investigational drug, a different dose, a device, or a placebo.
- A defined timeline. Trials have a start and an end. Standard of care continues indefinitely.
A Side by Side Look
- Who is in charge: your neurologist vs a study team coordinated with your neurologist.
- Cost: standard of care is billed to insurance; study related care is provided at no cost.
- Time commitment: existing visits vs additional study visits.
- What you get out of it: ongoing symptom management vs potential early access to a new treatment, deeper monitoring, and a contribution to research.
How to Think About Whether It Is Worth It
The trade off is mostly about time and energy. The potential upside is access to something not yet widely available, plus the satisfaction of contributing to research. The cost is more visits and a defined commitment. For some families, the extra structure is welcome. For others, it is too much. Both answers are reasonable.
For a lighter time commitment that layers easily on top of standard care, browse observational Parkinson's trials. For studies testing new treatments, browse interventional Parkinson's trials.